Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-04 Purchase |
2020-09-09 09:16 am |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
10,000 | $0.48 | $4,800 | 40,000 (Direct) |
View |
| 2020-08-24 Purchase |
2020-08-26 09:21 am |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
10,000 | $0.6112 | $6,112 | 30,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-11-03 5:48 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
0 | $0 | 119,873 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:39 pm |
2021-06-22 2023-06-22 |
EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director |
11,000 | $0 | 19,016 (Direct) |
View |
| 2021-06-22 Exercise |
2021-06-23 5:39 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director |
2,500 | $0 | 19,016 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:30 pm |
2022-02-09 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:30 pm |
2022-02-09 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:29 pm |
2022-02-09 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:29 pm |
2022-02-09 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
14,750 | $0 | 14,750 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:28 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
75,200 | $0 | 75,200 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:28 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
75,200 | $0 | 79,305 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:27 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
75,200 | $0 | 75,200 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:27 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO |
266,300 | $0 | 266,300 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-15 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO |
4,500 | $0 | 113,546 (Direct) |
View |
| 2021-06-14 Tax Withholding |
2021-06-15 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
417 | $9.72 | 12,595 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-15 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
1,420 | $0 | 12,595 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:26 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
1,423 | $10.81 | 15,697 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:26 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
4,105 | $0 | 15,697 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 7:25 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
1,702 | $10.81 | 11,485 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:25 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
4,105 | $0 | 11,485 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:24 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
2,150 | $0 | 2,150 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:22 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
1,900 | $0 | 1,900 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:22 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Godshall Douglas Evan Director |
1,900 | $0 | 5,516 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:22 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
1,900 | $0 | 1,900 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:21 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
1,900 | $0 | 5,900 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:21 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO |
12,467 | $0 | 121,512 (Direct) |
View |
| 2021-02-21 Exercise |
2021-02-23 9:01 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO |
13,717 | $0 | 110,297 (Direct) |
View |
| 2020-06-15 Ownership |
2021-02-11 4:05 pm |
N/A 2026-09-15 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy See Remarks |
249,764 | $0 | 256,000 (Direct) |
View |
Ownership |
2021-01-14 08:07 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | OcuMension Therapeutics 10% Owner |
0 | $0 | 3,010,722 (Direct) |
View |
Ownership |
2021-01-13 4:44 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Liu Ye Director |
0 | $0 | 3,010,722 (Indirect) |
View |